Dana-Farber Cancer Institute is retracting one paper and correcting others due to an investigation of data manipulation. Leaders within the institute are among those investigated, including CEO Laurie Glimcher and COO William Hahn. Claims started to be reviewed over a year ago, and a research integrity officer stated that the allegations are credible and being taken seriously. The institute has not dismissed any allegations based on scientific merit, and is in the process of working with journals to retract and correct the papers in question.
Source link
Dana-Farber researchers moving to retract paper in investigation
